B. K. Logan, A. L. Mohr, M. Friscia, A. J. Krotulski, D. M. Papsun et al., Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013???2016: A Review, Journal of Analytical Toxicology, vol.40, issue.7, pp.1-38, 2017.
DOI : 10.1093/jat/bkw013

M. A. Huestis, S. D. Brandt, S. Rana, V. Auwärter, and M. H. Baumann, Impact of Novel Psychoactive Substances on Clinical and Forensic Toxicology and Global Public Health, Clinical Chemistry, vol.63, issue.10, 2017.
DOI : 10.1373/clinchem.2017.274662

K. W. Simonsen, H. M. Edvardsen, G. Thelander, I. Ojanperä, S. Thordardottir et al., Fatal poisoning in drug addicts in the Nordic countries in 2012, Forensic Science International, vol.248, pp.172-180, 2015.
DOI : 10.1016/j.forsciint.2015.01.003

D. Lee, C. W. Chronister, W. A. Broussard, S. R. Utley-bobak, D. L. Schultz et al., Illicit Fentanyl-Related Fatalities in Florida: Toxicological Findings, Journal of Analytical Toxicology, vol.2, issue.8, pp.40-588, 2016.
DOI : 10.1081/ADA-120026256

A. L. Mohr, M. Friscia, D. Papsun, S. L. Kacinko, D. Buzby et al., Analysis of Novel Synthetic Opioids U-47700, p.50488

B. S. Huang, R. C. Terrell, K. H. Deutsche, L. V. Kudzma, and N. L. Lalinde, -piperidinyl)amides and Pharmaceutical Compositions and Method Employing Such Compounds, p.4584303, 1986.

F. G. Rudo, R. L. Wynn, M. Ossipov, R. D. Ford, B. A. Kutcher et al., Antinociceptive activity of pentamorphone, a 14-beta-aminomorphinone derivative, compared to fentanyl and morphine, Anesth. Analg, issue.4, pp.69-450, 1989.

E. N. Shoff, M. E. Zaney, J. H. Kahl, G. W. Hime, and D. M. Boland, Qualitative Identification of Fentanyl Analogs and Other Opioids in Postmortem Cases by UHPLC-Ion Trap-MSn, Journal of Analytical Toxicology, vol.65, issue.6, pp.1-9, 2017.
DOI : 10.15585/mmwr.mm655051e1

D. M. Swanson, L. S. Hair, S. R. Strauch-rivers, B. C. Smyth, S. C. Brogan et al., Fatalities Involving Carfentanil and Furanyl Fentanyl: Two Case Reports, Journal of Analytical Toxicology, vol.824, issue.6, pp.1-5, 2017.
DOI : 10.1016/j.jchromb.2005.05.048

S. A. Klar, E. Brodkin, E. Gibson, S. Padhi, C. Predy et al., Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine -British Columbia, Canada, Morb. Mortal. Wkly Rep, issue.37, pp.65-1015, 2016.

A. Helander, M. Bäckberg, and O. Beck, Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project, Clinical Toxicology, vol.63, issue.4, pp.54-324, 2016.
DOI : 10.1093/jat/23.4.280

D. Guerrieri, E. Rapp, M. Roman, H. Druid, and R. Kronstrand, Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related Deaths, Journal of Analytical Toxicology, vol.266, 2017.
DOI : 10.1111/j.1398-9995.1997.tb01256.x

S. Watanabe, S. Vikingsson, M. Roman, H. Green, R. Kronstrand et al., In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl, The AAPS Journal, vol.19, issue.4, pp.1102-1122, 2017.
DOI : 10.1208/s12248-017-0070-z

M. M. Goggin, A. Nguyen, and G. C. Janis, Identification of Unique Metabolites of the Designer Opioid Furanyl Fentanyl, Journal of Analytical Toxicology, vol.25, issue.5, pp.41-367, 2017.
DOI : 10.1021/tx3003824

A. V. Labutin, A. Z. Temerdashev, O. A. Dukova, E. V. Suvorova, and V. V. Nemihin, Identification of Furanoylfentanil and its Metabolites in Human Urine, J. Environ. Anal. Toxicol, 2017.

P. Gripon, S. Rumin, S. Urban, J. Le-seyec, D. Glaise et al., Infection of a human hepatoma cell line by hepatitis B virus, Proc. Natl. Acad. Sci. USA, pp.99-15655, 2002.

S. Akoka, L. Barantin, and M. Trierweiler, Concentration Measurement by Proton NMR Using the ERETIC Method, Analytical Chemistry, vol.71, issue.13, pp.2554-2557, 1999.
DOI : 10.1021/ac981422i

Y. Boumrah, L. Humbert, M. Phanithavong, K. Khimeche, A. Dahmania et al., characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS, Drug Testing and Analysis, vol.11, issue.2, pp.248-526, 2016.
DOI : 10.2174/138920010794233503

P. Kintz, C. Richeval, C. Jamey, A. Ameline, D. Allorge et al., Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism, Drug Testing and Analysis, vol.11, issue.7, 2016.
DOI : 10.2174/138920010794233503

D. Allorge and J. M. Gaulier, Retrospective identification of 25I-NBOMe metabolites in an intoxication case, Toxicologie Analytique et Clinique, vol.29, pp.71-81, 2017.

R. J. Dinis-oliveira, Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects, European Journal of Drug Metabolism and Pharmacokinetics, vol.69, issue.1
DOI : 10.1080/03602532.2016.1192642

H. H. Van-rooy, M. P. Vermeulen, and J. G. Bovill, The assay of fentanyl and its metabolites in plasma of patients using gas chromatography with alkali flame ionisation detection and gas chromatography???mass spectrometry, Journal of Chromatography B: Biomedical Sciences and Applications, vol.223, issue.1, pp.223-85, 1981.
DOI : 10.1016/S0378-4347(00)80070-5

B. Fromenty, A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: application to acetaminophen, Toxicol. Appl
URL : https://hal.archives-ouvertes.fr/hal-01255826

M. G. Feasel, A. Wohlfarth, J. M. Nilles, S. Pang, R. Kristovich et al., Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry, The AAPS Journal, vol.18, issue.6, pp.18-1489, 2016.
DOI : 10.1208/s12248-016-9963-5

R. B. Labroo, M. F. Paine, K. E. Thummel, and E. D. Kharasch, Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions, Drug Metab. Dispos, issue.9, pp.25-1072, 1997.

A. E. Steuer, E. Williner, S. N. Staeheli, and T. Kraemer, Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS), Drug Testing and Analysis, vol.53, issue.7
DOI : 10.1016/S0006-2952(96)00893-3

M. R. Meyer, J. Dinger, A. E. Schwaninger, D. K. Wissenbach, J. Zapp et al., Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography???linear ion trap???mass spectrometry (LC-MSn), Analytical and Bioanalytical Chemistry, vol.45, issue.3, pp.402-1249, 2012.
DOI : 10.1002/jms.1859

C. Emoto, N. Murayama, A. Rostami-hodjegan, and H. Yamazaki, Methodologies for Investigating Drug Metabolism at the Early Drug Discovery Stage: Prediction of Hepatic Drug Clearance and P450 Contribution, Current Drug Metabolism, vol.11, issue.8, pp.678-685, 2010.
DOI : 10.2174/138920010794233503

C. Aninat, A. Piton, D. Glaise, T. Le-charpentier, S. Langouët et al., EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS, Drug Metabolism and Disposition, vol.34, issue.1, pp.34-75, 2006.
DOI : 10.1124/dmd.105.006759
URL : https://hal.archives-ouvertes.fr/hal-00702085

A. Guillouzo, A. Corlu, C. Aninat, D. Glaise, and F. Morel, Guguen-Guillouzo, C. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics, Chem. Biol. Interact, issue.1, pp.168-66, 2007.

C. Guguen-guillouzo and . A. Guillouzo, Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells
URL : https://hal.archives-ouvertes.fr/hal-01134764

H. Al-attrache, A. Sharanek, M. Burbank, T. Gicquel, Z. Abdel-razzak et al., Differential sensitivity of metabolically competent and non-competent HepaRG cells to apoptosis induced by diclofenac combined or not with TNF-??, Toxicology Letters, vol.258, pp.71-86, 2016.
DOI : 10.1016/j.toxlet.2016.06.008
URL : https://hal.archives-ouvertes.fr/hal-01372855

L. H. Richter, V. Flockerzi, H. H. Maurer, and M. R. Meyer, Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using, p.5

P. Marquet and . Lc-ms-vs, LC-MS vs. GC-MS, Online Extraction Systems, Advantages of Technology for Drug Screening Assays, Methods Mol. Biol, vol.902, pp.15-27, 2012.
DOI : 10.1007/978-1-61779-934-1_2
URL : https://hal.archives-ouvertes.fr/inserm-00925553

R. Kronstrand, L. Brinkhagen, C. Birath-karlsson, M. Roman, and M. Josefsson, LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine, Analytical and Bioanalytical Chemistry, vol.200, issue.15, pp.3599-3609, 2014.
DOI : 10.1016/j.forsciint.2010.04.003